Concepedia

Elizabeth Erhardtsen

EE

4

Publications

523

Citations

4

H-Index

1995

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Elizabeth Erhardtsen is an author at Novo Nordisk (Denmark) specializing in hematology, medicine, and pharmacotherapy.

Top concepts

MedicineHematologyHealthOrthopedicsPharmacologyClinical TrialsPain ManagementPharmacotherapyRheumatoid ArthritisPathology

Publications per year

1995–2006

4

Publications

4

Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven<sup>®</sup>) in children vs. adults with haemophilia A

Ana Villar, S Aronis, Massimo Morfini et al. · Haemophilia · 2004 · 147 citations

Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.

Khan Kavakli, Bülent Zülfikar, Elizabeth Erhardtsen et al. · PubMed · 2006 · 146 citations

Single Dose Regimen, Robust Treatment, Pharmacotherapy +18

Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors

Khan Kavakli, Bülent Zülfikar, Elizabeth Erhardtsen et al. · Thrombosis and Haemostasis · 2006 · 137 citations

Single Dose Regimen, Robust Treatment, Pharmacotherapy +18

Blocking of tissue factor pathway inhibitor (TFPl) shortens the bleeding time in rabbits with antibody induced haemophilia A

Elizabeth Erhardtsen, Mirella Ezban, Michael Tvilling Madsen et al. · Blood Coagulation & Fibrinolysis · 1995 · 93 citations

Inflammation, Thrombosis, Factor X +15

Rows per page

1–4 of 4